Development and Justification of a Risk Evaluation Matrix To Guide Chemical Testing Necessary To Select and Qualify Plastic Components Used in Production Systems for Pharmaceutical Products

References

1. 1.↵
   1. Colton R.

   Recommendations for extractables and leachables testing. Part 1: Introduction, regulatory issues and risk assessment. BioProcess International 2007, 5 (11), 36, 38, 40, 42, 44.

   OpenUrl
2. 2.↵
   Equipment Construction. Code of Federal Regulations, Foods and Drugs Title 12, Part 211.65. U.S. Government Printing Office: Washington, DC. Revised April 1, 2006. Available at www.accessdata.fda.gov/scripts/cdhr/cfdocs/cfcfr/CFRSearch.
3. 3.↵
   EUDRALEX Volume 4: Good Manufacturing Practices, Medical Products for Human and Veterinary Use. European Commission: Brussels, Belgium, 1998. Available at http://ec.europa.eu/enterprise/pharaceuticals/eudralex/homev4.htm.
4. 4.↵
   ICH Harmonized Tripartite Guideline Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients. Q7. Step 4 Version; November 10, 2000. Available at http://www.ich.org/LOB/media/MEDIA433.pdf.
5. 5.↵
   1. Colton R.

   Recommendations for extractables and leachables testing. Part 2: Executing a program. BioProcess International 2008, 6 (1), 44, 46, 48, 50, 52.

   OpenUrl
6. 6.↵
   1. Tsui V.,
   2. Somma M. S.,
   3. Zitner L. A.

   Leachables evaluation for bulk drug substance. PDA J. Pharm. Sci. Technol. 2009, 63(2), 168–183.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   1. Yu X.,
   2. Wood D.,
   3. Dong X.

   Extractables and leachables study approach for disposable materials used in bioprocessing. BioProcess International 2008, 6(2), 42–51.

   OpenUrl
8. 8.↵
   1. Ding W.,
   2. Martin J.

   Implementing single-use technology in biopharmaceutical manufacturing—an approach to extractables/leachables studies. Part One: Connectors and filters. BioProcess International 2008, 6(9), 34–42.

   OpenUrl
9. 9.↵
   1. Ding W.,
   2. Martin J.

   Implementing single-use technology in biopharmaceutical manufacturing—an approach to extractables/leachables studies. Part Two: Tubing and biocontainers. BioProcess International 2009, 7(5), 48–55.

   OpenUrl
10. 10.↵
    1. Bestwick D.,
    2. Colton R.

    Extractables and leachables from single-use disposables. BioProcess International 2009, 7(Suppl. 1), 88–42.

    OpenUrl
11. 11.↵
    1. Jenke D.

    Compatibility of Pharmaceutical Products and Contact Materials, Safety Considerations Associated with Extractables and Leachables; Wiley: Hoboken, NJ, 2009.
12. 12.↵
    1. Jenke D.

    Essential aspects in assessing the safety impact of interactions between a drug product and its associated manufacturing system. PDA J. Pharm. Sci. Technol. 2012, 66(1), 63–77.

    OpenUrlAbstract/FREE Full Text
13. 13.↵
    1. Ding W.,
    2. Madsen G.,
    3. Mahajan E.,
    4. O'Connor S.,
    5. Wong K.

    Standardized extractables testing protocol for single-use systems used in biomanufacturing. Pharm. Eng. 2014, 34(6), 1–11.

    OpenUrl
14. 14.↵
    Guidance for Industry. Container Closure Systems for Packaging Human Drugs and Biologics. U.S. Department of Health and Human Services, Food and Drug Administration: Rockville, MD, May, 1999.
15. 15.↵
    1. Brennan J.,
    2. Bing F.,
    3. Boone H.,
    4. Fernandez J.,
    5. Miller D.,
    6. Seeley B.,
    7. Van Denise H.

    Evaluation of extractables from product-contact surfaces. BioPharm Int. 2002, 15(12), 23–34.

    OpenUrl
16. 16.↵
    1. Green S.

    Assessing polymeric extractables and leachables for biopharmaceutical manufacturing. Am. Pharm. Rev. 2007, 10 (6): 88, 90, 92–94.

    OpenUrl
17. 17.↵
    1. Wakankar A. A.,
    2. Wang Y.J.,
    3. Canova-Davis E.,
    4. Ma S.,
    5. Schmalzing D.,
    6. Grieco J.,
    7. Milby T.,
    8. Reynolds T.,
    9. Mazzarella K.,
    10. Hoff E.,
    11. Gomez S.,
    12. Martin-Moe S.

    On developing a process for conducting extractable-leachable assessment of components used for storage of biopharmaceuticals. J. Pharm. Sci. 2010, 99(5), 2209–2218.

    OpenUrlPubMed
18. 18.↵
    1. Cruz L. A.,
    2. Jenke M. P.,
    3. Kenley R. A.,
    4. Chen M. J.,
    5. Jenke D. R.

    Influence of solute degradation on the accumulation of solutes migrating into solution from polymeric parenteral containers. Pharm. Res. 1990, 7(9), 967–972.

    OpenUrlPubMed
19. 19.↵
    1. Franz R.,
    2. Stormer A.

    Migration of Plastic Constituents. In Plastic Packaging: Interactions with Foods and Pharmaceuticals, 2nd ed.; Wiley-VCH: Weinheim, Germany, 2008; p 368.
20. 20.↵
    1. Jenke D.

    Establishing the proper pH of simulating solvents used in organic extractables assessments for packaging systems and their materials of construction used with aqueous parenteral drug products. Pharm. Outsourcing 2014, 15 (4), 20, 22, 24–27.

    OpenUrl
21. 21.↵
    1. Jenke D.,
    2. Liu N.,
    3. Hua Y.,
    4. Swanson S.,
    5. Bogseth R.

    A means of establishing and justifying binary ethanol/water mixtures as simulating solvents in extractables studies. PDA J. Pharm. Sci. Technol. 2015, 69(3), 366–382.

    OpenUrlAbstract/FREE Full Text
22. 22.↵
    1. Dole P.,
    2. Feigenbaum A. E.,
    3. De La Cruz C.,
    4. Pastorelli S.,
    5. Paseiro P.,
    6. Hankemeier T.,
    7. Voulzatis Y.,
    8. Aucejo S.,
    9. Saillard P.,
    10. Papaspyrides C.

    Typical diffusion behavior in packaging polymers—application to functional barriers. Food Additives & Contaminants 2006, 23(2), 202–211.

    OpenUrlPubMed
23. 23.
    1. Begley T.,
    2. Castle L.,
    3. Feigenbaum A.,
    4. Franz R.,
    5. Hinrichs K.,
    6. Lickly T.,
    7. Mercea P.,
    8. Milana M.,
    9. O'Brien A.,
    10. Rebre S.,
    11. Rijk R.,
    12. Piringer O.

    Evaluation of migration models that might be used in support of regulations for food-contact plastics. Food Additives & Contaminants 2005, 22(1), 73–90.

    OpenUrlPubMed
24. 24.↵
    1. Stults C. L. M.,
    2. Ansell J. M.,
    3. Shaw A. J.,
    4. Nagao L. M.

    Evaluation of extractables in processed and unprocessed polymer materials used for pharmaceutical applications. AAPS PharmSciTech 2014, 16(1), 150–164.

    OpenUrlPubMed
25. 25.↵
    1. Estrand C. W.,
    2. Schafbuch J.,
    3. Johnson M. W.

    The influence of polymer processing on extractables and leachables. BioProcess Int. 2013, 11 (4), 36, 38, 39.

    OpenUrl
26. 26.↵
    1. Jenke D.,
    2. Zietlow D.,
    3. Sadan S.

    Leaching of organic acids from irradiated EVA plastic as a function of solution pH and polarity. PDA J. Pharm. Sci. Technol. 2004, 58(1), 24–31.

    OpenUrlAbstract/FREE Full Text
27. 27.↵
    1. Chen H.,
    2. Wu Y.,
    3. Fu X.,
    4. Xia Z.

    Direct determination of acetophenone in ethylene vinyl acetate plastic by microwave assisted solid headspace-gas chromatography. Fenxi Huaxue 2012, 40(6), 904–908.

    OpenUrl
28. 28.↵
    1. Azuma K.,
    2. Hirata T.,
    3. Tsunoda H.,
    4. Ishitani T.,
    5. Tanaka Y.

    Identification of volatiles from low density polyethylene film irradiated with an electron beam. Agric. Biol. Chem. 1983, 47(4), 855–860.

    OpenUrl
29. 29.↵
    1. Azuma K.,
    2. Tanaka Y.,
    3. Tsunoda H.,
    4. Hirata T.,
    5. Ishitani T.

    Effects of film variety on the amounts of carboxylic acids from electron beam irradiated polyethylene film. Agric. Biol. Chem. 1984, 48(8), 2003–2008.

    OpenUrl
30. 30.↵
    1. Buchalla R.,
    2. Boess C.,
    3. Bogl K. W.

    Characterization of volatile radiolysis products in radiation-sterilized plastics by thermal desorption-gas chromatography-mass spectrometry; screening of six medical plastics. Rad. Phys. Chem. 1999, 56(3), 353–367.

    OpenUrl
31. 31.↵
    1. Buchalla R.,
    2. Boess C.,
    3. Bogl K. W.

    Analysis of volatile radiolysis products in gamma-irradiated LDPE and polypropylene films by thermal desorption-gas chromatography-mass spectrometry. Appl. Rad. Isotopes 2000, 52(2), 251–269.

    OpenUrl
32. 32.↵
    1. Chytiri S.,
    2. Goulas A. E.,
    3. Badeka A.,
    4. Riganakos K. A.,
    5. Kontominas M. G.

    Volatile and non-volatile radiolysis products in irradiated multilayer coextruded food-packaging films containing a buried layer of recycled low-density polyethylene. Food Additives & Contaminants 2005, 22(12), 1264–1273.

    OpenUrlPubMed
33. 33.↵
    1. Jenke D.,
    2. Barge V. J.

    Factors affecting the release of extractable acetic acid from multi-layered plastic films containing ethylene vinyl acetate (EVA) and polyethylene (PE) layers. Pharm. Outsourcing 2014, 15 (3), 52, 54, 56–59.

    OpenUrl
34. 34.↵
    1. Hammond M.,
    2. Nunn H.,
    3. Rogers G.,
    4. Lee H.,
    5. Marghitoiu A. L.,
    6. Perez L.,
    7. Nashed-Samuel Y.,
    8. Anderson C.,
    9. Vandiver M.,
    10. Kline S.

    Identification of a leachable compound detrimental to cell growth in single-use bioprocess containers. PDA J. Pharm. Sci. Technol. 2013, 67(2), 123–134.

    OpenUrlAbstract/FREE Full Text
35. 35.↵
    1. Norwood D. L.,
    2. Mullis J. O.

    “Special case” leachables: a brief review. Am. Pharm. Rev. 2009, 12(3), 79–86.

    OpenUrl
36. 36.↵
    Product Quality Research Institute (PQRI), Leachables and Extractables Working Group. Safety Thresholds and Best Practices for Extractables and Leachables in Orally Inhaled and Nasal Drug Products. Product Quality Research Institute: Arlington, VA, 2006.
37. 37.↵
    1. Markovic I.

    Challenges associated with extractable and/or leachable substances in therapeutic biologic protein products. Am. Pharm. Rev. 2006, 9 (6), 20, 22, 24–27.

    OpenUrl
38. 38.↵
    1. Liu W.,
    2. Swift R.,
    3. Torraca G.,
    4. Nashed-Samuel Y.,
    5. Wen Z. Q.,
    6. Jiang Y.,
    7. Vance A.,
    8. Mire-Sluis A.,
    9. Freund E.,
    10. Davis J.,
    11. Narhi L.

    Root cause analysis of tungsten-induced protein aggregation in pre-filled syringes. PDA J. Pharm. Sci. Technol. 2010, 64(1), 11–19.

    OpenUrlAbstract/FREE Full Text
39. 39.↵
    1. Seidl A.,
    2. Hainzl O.,
    3. Richter M.,
    4. Fischer R.,
    5. Böhm S.,
    6. Deutel B.,
    7. Hartinger M.,
    8. Windisch J.,
    9. Casadevall N.,
    10. London G. M.,
    11. Macdougall I.

    Tungsten-induced denaturation and aggregation of epoetin alfa during primary packaging as a cause of immunogenicity. Pharm. Res. 2012, 29(6), 1454–1467.

    OpenUrlCrossRefPubMed
40. 40.↵
    1. Hammond M.,
    2. Marghitoiu A. L.,
    3. Lee H.,
    4. Lourdes P.,
    5. Rogers G.,
    6. Nashed-Samuel Y.,
    7. Nunn H.,
    8. Kline S.

    A cytotoxic leachable compound from single-use bioprocess equipment that causes poor cell growth performance. Biotechnol. Prog. 2014, 30(2), 332–337.

    OpenUrl
41. 41.↵
    International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. Draft Consensus Guideline. Guideline for Elemental Impurities. Q3D. Current Step 4 Version, December 16, 2014.
42. 42.↵
    1. Killian P. F.

    Assessing the risk of leachables from single-use systems. Biopharm Int. 2012, 25 (2), 32, 34–36, 39, 40.

    OpenUrl
43. 43.↵
    1. Lee K.

    Extractables and Leachables from Single-Use Components—Can They Be Cleared through Ultrafiltration/Diafiltration (UF/DF) Process? Presented at the Cambridge Healthtech Institute's 14th Annual PepTalk, San Diego, CA, January 19, 2015.
44. 44.↵
    Guidance for Industry. Genotoxic and Carcinogenic Impurities in Drug Substances and Products: Recommended Approaches. U.S. Department of Health and Human Services, Food and Drug Administration: Rockville, MD, December, 2008.
45. 45.↵
    1. Norwood D. L.,
    2. Nagao L. M.,
    3. Stults C. L. M.

    Perspectives on the PQRI extractables and leachables “safety thresholds and best practices” recommendations for inhalation drug products. PDA J. Pharm. Sci. Technol. 2013, 67(5), 413–429.

    OpenUrlAbstract/FREE Full Text
46. 46.↵
    <661.1> Plastic materials of construction. Pharm. Forum 2014, 40 (5). Available at http://www.usppf.com/pf/pub/data/v405/CHA_IPR_405_C661.1.xml.
47. 47.↵
    <661.2> Plastic packaging systems for pharmaceutical use. Pharm. Forum 2014, 40 (5). Available at http://www.usppf.com/pf/pub/data/v405/CHA_IPR_405_C661.2.xml.
48. 48.↵
    <1663> Assessment of extractables associated with pharmaceutical packaging/delivery systems. Pharm. Forum 2013, 39 (5). Available at http://www.usppf.com/pf/pub/data/v395/CHA_IPR_395_C1663.xml.
49. 49.↵
    <1031> The Biocompatibility of Materials Used in Drug Container. In USP 37-NF32; USP Convention: Rockville, MD, 2014; pp 564–573.
50. 50.
    1. Paskiet D.,
    2. Egert T.

    Biopharmaceutical Quality: Factoring Risk into the Extractables Equation. Presented at the Cambridge Healthtech Institute's 14th Annual PepTalk, San Diego, January 22, 2015.